Clinical Trial Update: An 18-month Prospective Natural History Study to Gain Insight Into FSHD2 Pathophysiology and Disease Progression [NA]

View source ↗

Summary

This document describes an 18-month prospective natural history study to gain insight into FSHD2 pathophysiology and disease progression. The study is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Facioscapulohumeral Muscular Dystrophy Type

Snippet

Sponsor: Centre Hospitalier Universitaire de Nice | Conditions: Facioscapulohumeral Muscular Dystrophy Type 2 | NA | Status: RECRUITING